SCHEDULE: FMR LLC & Abigail Johnson Disclose 5.4% Praxis Stake
Beneficial Ownership Disclosure
FMR LLC and Abigail P. Johnson have disclosed a 5.4% beneficial ownership stake in Praxis Precision Medicines Inc. common stock as of December 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson collectively reported beneficial ownership of 1,353,275.05 shares of Praxis Precision Medicines Inc. common stock.
- This aggregate amount represents 5.4% of the total outstanding common stock of Praxis Precision Medicines Inc.
- FMR LLC holds sole voting power over 1,351,591.00 shares and sole dispositive power over 1,353,275.05 shares.
- Abigail P. Johnson holds sole dispositive power over 1,353,275.05 shares, with no sole or shared voting power directly attributed.
- The filing was made under Rule 13d-1(b), indicating the securities were acquired and held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral disclosure, typical for a Schedule 13G filing, indicating a passive ownership stake without explicit positive or negative implications for the company's operational performance.
Industry Context
StockSavvy.ai notes that institutional filings like this Schedule 13G provide transparency into significant ownership stakes, which can sometimes signal institutional confidence or a passive investment strategy in the biotechnology sector, where Praxis Precision Medicines operates.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Ownership Structure Disclosure | Disclosure that members of the Johnson family, including Abigail P. Johnson, are predominant owners of Series B voting common shares of FMR LLC, representing 49% of voting power, and have a shareholders' voting agreement to vote all Series B shares in accordance with the majority vote. This may deem them a controlling group with respect to FMR LLC under the Investment Company Act of 1940. | Clarifies the control structure of FMR LLC, the reporting entity, rather than Praxis Precision Medicines Inc. directly. |
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, which could be viewed as a vote of confidence or simply a passive investment.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2025-12-31 | Date of event requiring the filing of this statement (beneficial ownership as of this date). |
| 2026-02-04 | Filing date of the Schedule 13G. |
Keywords
Praxis Precision Medicines, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Ownership, Biotechnology, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.